Study casts light on toxicity mechanism behind Parkinson’’s diseaseJanuary 2nd, 2009 - 1:35 pm ICT by ANI
Washington, January 2 (ANI): Scientists at Emory University School of Medicine have announced the identification of a mechanism behind the development of clumps of aggregated proteins inside cells, a hallmark of Parkinson’’s and other neurodegenerative diseases.
The researchers say that the build up of these clumps, also known as Lewy bodies, may be prevented by targeting a survival circuit called MEF2D, which is sensitive to the main component of Lewy bodies, a protein called alpha-synuclein.
Writing about their study in the journal Science, they have revealed that in cell cultures and animal models of Parkinson’’s, an accumulation of alpha-synuclein interferes with the cell’’s recycling of MEF2D, leading to cell death.
The team have found that MEF2D is especially abundant in the brains of people with Parkinson’’s.
“We”ve identified what could be an important pathway for controlling cell loss and survival in Parkinson’’s disease,” says senior author Dr. Zixu Mao, associate professor of pharmacology at Emory University School of Medicine.
He says that future studies may lead to the identification of effective drugs to regulate MEF2D, allowing brain cells to survive toxic stresses that impair protein recycling.
While most Parkinsons cases do not have any obvious genetic cause, some inherited forms of the disease may be linked to mutations in the gene for alpha-synuclein or triplications of the gene, which cause the brain to produce either a toxic form of alpha-synuclein or more alpha-synuclein than normal.
“Somehow it’’s toxic, but alpha-synuclein isn”t part of the cell’’s machinery of death and survival,” Mao says.
During their study, Mao and his colleagues found that mice that artificially overproduce alpha-synuclein had elevated levels of apparently inactive MEF2D in their brains.
The researchers also observed that MEF2D protein levels were higher in the brains of Parkinson’’s patients than in controls.
Based on their observations, they came to the conclusion that following the influence of alpha-synuclein on MEF2D may be a way to connect the various genetic and environmental risk factors for Parkinson’’s.
“It may be that various stresses impact MEF2D in different ways. We think this work provides an explanation that ties several important observations together,” he says. (ANI)
- Toxin that plays key role in triggering Parkinson's disease identified - Feb 11, 2011
- Yeast offers clues to Parkinson's disease - Sep 09, 2010
- Turmeric compound shows promise in Parkinson's - Mar 21, 2012
- Protein pathway find may help solve Parkinson's disease - Mar 01, 2011
- Study provides new insight into Parkinson's disease - Apr 05, 2011
- How Parkinson's disease spreads in the brain - Jul 28, 2009
- Now, a new approach to calculate gene, protein connections in a Parkinson''s disease - Feb 23, 2009
- Blood-related genetic mechanisms critical to Parkinson''s identified - Jul 22, 2008
- New tests to detect Parkinson's disease early on - Sep 27, 2010
- Two genes tell how Parkinson's progresses - Feb 13, 2012
- Molecules that protect brain cells from Parkinson's identified - Dec 29, 2009
- Mouse model confirms mutated protein plays role in dementia - Nov 03, 2010
- Scientists identify 'molecule trio' that kills neurons in Parkinson's - Apr 30, 2009
- 'Key player' that facilitates Parkinson's disease found - Mar 04, 2011
- Sense of smell test key to tackling Parkinson's disease - Jun 12, 2010
Tags: accumulation, alpha synuclein, animal models, brain cells, cell cultures, cell death, clumps, emory university school, emory university school of medicine, future studies, genetic cause, impair, journal science, lewy bodies, mutations, neurodegenerative diseases, parkinson s disease, parkinsons, protein levels, school of medicine